PPAR-contributes to the anti-inflammatory activity of verbascoside in a model of inflammatory bowel disease in mice

PPAR Research

Volumn , Issue , 2010, Pages

  Cuzzocrea, Salvatore ^a,b   Esposito, Emanuela ^a,b   Mazzon, Emanuela ^b   Paterniti, Irene ^a   Dal Toso, Roberto ^c   Pressi, Giovanna ^c   Caminiti, Rocco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c IRB Srl Altavilla   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ACTEOSIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SULFONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; COLON INJURY; CONTROLLED STUDY; DRUG EFFICACY; ENTERITIS; HISTOPATHOLOGY; INTESTINE MUCOSA PERMEABILITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN;

EID: 77955365610     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/917312     Document Type: Article

References (45)

1. Cuzzocrea S., Emerging biotherapies for inflammatory bowel disease Expert Opinion on Emerging Drugs 2003 8 2 339 347
2. Matsumoto S., Okabe Y., Setoyama H., Takayama K., Ohtsuka J., Funahashi H., Imaoka A., Okada Y., Umesaki Y., Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain Gut 1998 43 1 71 78
3. Blumberg R. S., Saubermann L. J., Strober W., Animal models of mucosal inflammation and their relation to human inflammatory bowel disease Current Opinion in Immunology 1999 11 6 648 656
4. Mazzon E., Puzzolo D., Caputi A. P., Cuzzocrea S., Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis Molecular Medicine 2002 8 7 353 366
5. Neve B. P., Corseaux D., Chinetti G., Zawadzki C., Fruchart J.-C., Duriez P., Staels B., Jude B., PPAR agonists inhibit tissue factor expression in human monocytes and macrophages Circulation 2001 103 2 207 212
6. Escher P., Braissant O., Basu-Modak S., Michalik L., Wahli W., Desvergne B., Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding Endocrinology 2001 142 10 4195 4202
7. Mansn A., Guardiola-Diaz H., Rafter J., Branting C., Gustafsson J.-., Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa Biochemical and Biophysical Research Communications 1996 222 3 844 851
8. Okamoto H., Iwamoto T., Kotake S., Momohara S., Yamanaka H., Kamatani N., Inhibition of NK-B signaling by fenofibrate, a peroxisome proliferator- activated receptor-ligand, presents a therapeutic strategy for rheumatoid arthritis Clinical and Experimental Rheumatology 2005 23 3 323 330
9. Cuzzocrea S., Mazzon E., Di Paola R., Peli A., Bonato A., Britti D., Genovese T., Mui C., Crisafulli C., Caputi A. P., The role of the peroxisome proliferator-activated receptor-(PPAR-) in the regulation of acute inflammation Journal of Leukocyte Biology 2006 79 5 999 1010 (Pubitemid 44835587)
10. Korkina L. G., Phenylpropanoids as naturally occurring antioxidants: from plant defense to human health Cellular and Molecular Biology 2007 53 1 15 25
11. Afanas'ev I. B., Superoxide and nitric oxide in pathological conditions associated with iron overload. The effects of antioxidants and chelators Current Medicinal Chemistry 2005 12 23 2731 2739
12. Kris-Etherton P. M., Hecker K. D., Bonanome A., Coval S. M., Binkoski A. E., Hilpert K. F., Griel A. E., Etherton T. D., Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer American Journal of Medicine 2002 113 9, supplement 2 71S 88S
13. Minghetti P., Casiraghi A., Cilurzo F., Montanari L., Development of local patches containing melilot extract and ex vivo-in vivo evaluation of skin permeation European Journal of Pharmaceutical Sciences 2000 10 2 111 117
14. Korkina L. G., Mikhal'chik E. V., Suprun M. V., Pastore S., Dal Toso R., Molecular mechanisms underlying wound healing and anti-inflammatory properties of naturally occurring biotechnologically produced phenylpropanoid glycosides Cellular and Molecular Biology 2007 53 5 84 91
15. Mazzon E., Esposito E., Di Paola R., Riccardi L., Caminiti R., Dal Toso R., Pressi G., Cuzzocrea S., Effects of verbascoside biotechnologically produced by Syringa vulgaris plant cell cultures in a rodent model of colitis Naunyn-Schmiedeberg's Archives of Pharmacology 2009 380 1 79 94
16. Sturiale S., Barbara G., Qiu B., Figini M., Geppetti P., Gerard N., Gerard C., Grady E. F., Bunnett N. W., Collins S. M., Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P Proceedings of the National Academy of Sciences of the United States of America 1999 96 20 11653 11658
17. Mullane K. M., Kraemer R., Smith B., Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium Journal of Pharmacological Methods 1985 14 3 157 167
18. Mazzon E., Sautebin L., Caputi A. P., Cuzzocrea S., 5-lipoxygenase modulates the alteration of paracellular barrier function in mice ileum during experimental colitis Shock 2006 25 4 377 383
19. Bethea J. R., Castro M., Keane R. W., Lee T. T., Dietrich W. D., Yezierski R. P., Traumatic spinal cord injury induces nuclear factor-B activation Journal of Neuroscience 1998 18 9 3251 3260
20. Cuzzocrea S., Di Paola R., Mazzon E., Genovese T., Mui C., Centorrino T., Caputi A. P., Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-) in the development of inflammatory bowel disease in mice Laboratory Investigation 2004 84 12 1643 1654
21. Yoon J.-H., Baek S. J., Molecular targets of dietary polyphenols with anti-inflammatory properties Yonsei Medical Journal 2005 46 5 585 596
22. Kim S., Shin H.-J., Kim S. Y., Kim J. H., Lee Y. S., Kim D.-H., Lee M.-O., Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPAR Molecular and Cellular Endocrinology 2004 220 1-2 51 58
23. Xu J., Fu Y., Chen A., Activation of peroxisome proliferator-activated receptor-contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth American Journal of Physiology 2003 285 1 G20 G30
24. Becker J., Delayre-Orthez C., Frossard N., Pons F., Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? Fundamental and Clinical Pharmacology 2006 20 5 429 447
25. Chung J. H., Seo A. Y., Chung S. W., Kim M. K., Leeuwenburgh C., Yu B. P., Chung H. Y., Molecular mechanism of PPAR in the regulation of age-related inflammation Ageing Research Reviews 2008 7 2 126 136
26. Xiong Q., Kadota S., Tani T., Namba T., Antioxidative effects of phenylethanoids from Cistanche deserticola Biological and Pharmaceutical Bulletin 1996 19 12 1580 1585
27. Wong I. Y. F., He Z.-D., Huang Y., Chen Z.-Y., Antioxidative activities of phenylethanoid glycosides from Ligustrum purpurascens Journal of Agricultural and Food Chemistry 2001 49 6 3113 3119
28. Xiong Q., Tezuka Y., Kaneko T., Li H., Tran L. Q., Hase K., Namba T., Kadota S., Inhibition of nitric oxide by phenylethanoids in activated macrophages European Journal of Pharmacology 2000 400 1 137 144
29. Lee J. Y., Woo E.-R., Kang K. W., Inhibition of lipopolysaccharide- inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation Journal of Ethnopharmacology 2005 97 3 561 566
30. Lee J. H., Ji Y. L., Hyo S. K., Chan H. J., Moon H., Wan K. W., Chang J. K., Sang S. S., The effect of acteoside on histamine release and arachidonic acid release in RBL-2H3 mast cells Archives of Pharmacal Research 2006 29 6 508 513
31. Hollander D., Intestinal permeability, leaky gut, and intestinal disorders Current Gastroenterology Reports 1999 1 5 410 416
32. Bjarnason I., Maxton D., Reynolds A. P., Catt S., Peters T. J., Menzies I. S., Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease Scandinavian Journal of Gastroenterology 1994 29 7 630 639
33. Jenkins R. T., Chem C., Jones D. B., Goodacre R. L., Collins S. M., Coates G., Hunt R. H., Bienenstock J., Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases American Journal of Gastroenterology 1987 82 11 1159 1164
34. Zhang Y., Lee B., Thompson M., Glass R., Lee R. C., Figueroa D., Gilman R., Taylor D., Stephenson C., Lactulosemannitol intestinal permeability test in children with diarrhea caused by rotavirus and Cryptosporidium. Diarrhea Working Group Journal of Pediatric Gastroenterology and Nutrition 2000 31 1 16 21
35. Alam A. N., Sarker S. A., Wahed M. A., Khatun M., Rahaman M. M., Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation Gut 1994 35 12 1707 1711
36. Zuckerman M. J., Watts M. T., Bhatt B. D., Ho H., Intestinal permeability to [51Cr]EDTA in infectious diarrhea Digestive Diseases and Sciences 1993 38 9 1651 1657
37. Schrander J. J. P., Unsalan-Hooyen R. W. M., Forget P. P., Jansen J., [51Cr]EDTA intestinal permeability in children with cow's milk intolerance Journal of Pediatric Gastroenterology and Nutrition 1990 10 2 189 192
38. Ukabam S. O., Mann R. J., Cooper B. T., Small intestinal permeability to sugars in patients with atopic eczema British Journal of Dermatology 1984 110 6 649 652
39. Bjarnason I., MacPherson A., Hollander D., Intestinal permeability: an overview Gastroenterology 1995 108 5 1566 1581
40. Juby L. D., Rothwell J., Axon A. T. R., Lactulose/mannitol test: an ideal screen for celiac disease Gastroenterology 1989 96 1 79 85
41. Vogelsang H., Genser D., Wyatt J., Lochs H., Ferenci P., Granditsch G., Penner E., Screening for celiac disease: a prospective study on the value of noninvasive tests American Journal of Gastroenterology 1995 90 3 394 398
42. Hamilton I., Cobden I., Rothwell J., Axon A. T. R., Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge Gut 1982 23 3 202 210
43. Wyatt J., Vogelsang H., Hubl W., Waldhoer T., Lochs H., Intestinal permeability and the prediction of relapse in Crohn's disease Lancet 1993 341 8858 1437 1439
44. D'Inc R., Di Leo V., Corrao G., Martines D., D'Odorico A., Mestriner C., Venturi C., Longo G., Sturniolo G. C., Intestinal permeability test as a predictor of clinical course in Crohn's disease American Journal of Gastroenterology 1999 94 10 2956 2960
45. Lovett-Racke A. E., Hussain R. Z., Northrop S., Choy J., Rocchini A., Matthes L., Chavis J. A., Diab A., Drew P. D., Racke M. K., Peroxisome proliferator-activated receptor agonists as therapy for autoimmune disease Journal of Immunology 2004 172 9 5790 5798